LeJemtel TH - Search Results

1

Growth hormone resistance in severe heart failure resolves after cardiac transplantation.

Lund LH, Freda P, Williams JJ, LaManca JJ, LeJemtel TH, Mancini DM. Lund LH, et al. Among authors: lejemtel th. Eur J Heart Fail. 2009 May;11(5):525-8. doi: 10.1093/eurjhf/hfp044. Epub 2009 Apr 19. Eur J Heart Fail. 2009. PMID: 19380328 Free PMC article.

2

Intravenous use of amrinone for the treatment of the failing heart.

Mancini D, LeJemtel T, Sonnenblick E. Mancini D, et al. Am J Cardiol. 1985 Jul 22;56(3):8B-15B. doi: 10.1016/0002-9149(85)91189-0. Am J Cardiol. 1985. PMID: 2411122 Review.

3

Inotropic drugs for the treatment of heart failure.

Mancini DM, Keren G, Aogaichi K, LeJemtel TH, Sonnenblick EH. Mancini DM, et al. Among authors: lejemtel th. J Clin Pharmacol. 1985 Oct;25(7):540-54. doi: 10.1177/009127008502500710. J Clin Pharmacol. 1985. PMID: 2866200 Review. No abstract available.

4

Central and peripheral components of cardiac failure.

Mancini DM, Le Jemtel TH, Factor S, Sonnenblick EH. Mancini DM, et al. Am J Med. 1986 Feb 28;80(2B):2-13. doi: 10.1016/0002-9343(86)90138-5. Am J Med. 1986. PMID: 2936238 Review.

5

New positive inotropic drugs for the treatment of congestive heart failure.

Sonnenblick EH, Mancini DM, LeJemtel TH. Sonnenblick EH, et al. Among authors: lejemtel th. Am J Cardiol. 1985 Jan 11;55(2):41A-44A. doi: 10.1016/0002-9149(85)90795-7. Am J Cardiol. 1985. PMID: 2981465

6

CI-930, a new cardiotonic and vasodilating agent: hemodynamic comparison to dobutamine and long-term clinical effects.

Mancini D, Keren G, Sonnenblick EH, LeJemtel TH. Mancini D, et al. Among authors: lejemtel th. Am Heart J. 1988 Oct;116(4):1008-16. doi: 10.1016/0002-8703(88)90152-4. Am Heart J. 1988. PMID: 3177174

7

Dependence of enhanced maximal exercise performance on increased peak skeletal muscle perfusion during long-term captopril therapy in heart failure.

Mancini DM, Davis L, Wexler JP, Chadwick B, LeJemtel TH. Mancini DM, et al. Among authors: lejemtel th. J Am Coll Cardiol. 1987 Oct;10(4):845-50. doi: 10.1016/s0735-1097(87)80279-6. J Am Coll Cardiol. 1987. PMID: 3309004 Free article.

8

Systemic and regional hemodynamic effects of captopril and milrinone administered alone and concomitantly in patients with heart failure.

LeJemtel TH, Maskin CS, Mancini D, Sinoway L, Feld H, Chadwick B. LeJemtel TH, et al. Circulation. 1985 Aug;72(2):364-9. doi: 10.1161/01.cir.72.2.364. Circulation. 1985. PMID: 3891133

9

Angiotensin II-receptor blockade further reduces afterload safely in patients maximally treated with angiotensin-converting enzyme inhibitors for heart failure.

Hamroff G, Blaufarb I, Mancini D, Katz SD, Bijou R, Jondeau G, Olivari MT, Thomas S, LeJemtel TH. Hamroff G, et al. Among authors: lejemtel th. J Cardiovasc Pharmacol. 1997 Oct;30(4):533-6. doi: 10.1097/00005344-199710000-00020. J Cardiovasc Pharmacol. 1997. PMID: 9335416 Clinical Trial.

10

Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure.

Hamroff G, Katz SD, Mancini D, Blaufarb I, Bijou R, Patel R, Jondeau G, Olivari MT, Thomas S, Le Jemtel TH. Hamroff G, et al. Circulation. 1999 Mar 2;99(8):990-2. doi: 10.1161/01.cir.99.8.990. Circulation. 1999. PMID: 10051289 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

308 results

Search Page

Filters